The amino acid on which the research is based is already common in many medications and supplements.

A major review challenges a long-standing strategy in Alzheimer’s research, suggesting that removing a hallmark brain protein may not lead to meaningful improvements for patients.

For decades, the brain’s own immune cells have watched Alzheimer’s plaques accumulate and done almost nothing about it. Now a ...

Scientists in Japan found that arginine, a common amino acid already used in supplements and medicine, reduced harmful ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...

Scientists have discovered a way to help the brain clean itself of harmful Alzheimer’s plaques by activating its own support cells. By increasing a protein called Sox9, researchers were able to boost ...

Arginine found in nuts, legumes, dairy, and meat may help reduce Alzheimer’s-related brain changes and inflammation.

A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of ...

A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found that treatment using the drug lecanemab to remove amyloid plaques in the ...

Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...

Arginine reduced Alzheimer's plaques and improved memory in mice, offering hope for future medical treatments.

A new study led by researchers from VIB and KU Leuven shows that immune cells called microglia can actively promote the formation of plaques in Alzheimer's disease, challenging the long-standing view ...